ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Befesa SA (PK)

Befesa SA (PK) (BFSAF)

27.75
0.00
( 0.00% )
업데이트: 23:17:09

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
27.75
매수가
19.90
매도가
22.80
거래량
-
0.00 일간 변동폭 0.00
27.75 52주 범위 27.75
market_cap
전일 종가
27.75
개장가
-
최근 거래 시간
마지막 거래 시간
-
재정 규모
-
VWAP
-
평균 볼륨(3m)
-
발행 주식
39,999,998
배당수익률
-
주가수익률
19.15
주당순이익(EPS)
1.45
매출
1.22B
순이익
57.97M

Befesa SA (PK) 정보

섹터
Scrap & Waste Materials-whsl
산업
Scrap & Waste Materials-whsl
웹사이트
본부
Luxembourg City, Luxembourg, Lux
설립됨
-
Befesa SA (PK) is listed in the Scrap & Waste Materials-whsl sector of the OTC 시장 with ticker BFSAF. The last closing price for Befesa (PK) was US$27.75. Over the last year, Befesa (PK) shares have traded in a share price range of US$ 27.75 to US$ 27.75.

Befesa (PK) currently has 39,999,998 shares in issue. The market capitalisation of Befesa (PK) is US$1.11 billion. Befesa (PK) has a price to earnings ratio (PE ratio) of 19.15.

BFSAF 최신 뉴스

No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260027.7527.7527.7500CS
520027.7527.7527.7500CS
156-47.75-63.245033112675.575.527.7592667.72367012CS
260-43.8369-61.235924449971.586975.527.75102468.26239971CS

BFSAF - Frequently Asked Questions (FAQ)

What is the current Befesa (PK) share price?
The current share price of Befesa (PK) is US$ 27.75
How many Befesa (PK) shares are in issue?
Befesa (PK) has 39,999,998 shares in issue
What is the market cap of Befesa (PK)?
The market capitalisation of Befesa (PK) is USD 1.11B
What is the 1 year trading range for Befesa (PK) share price?
Befesa (PK) has traded in the range of US$ 27.75 to US$ 27.75 during the past year
What is the PE ratio of Befesa (PK)?
The price to earnings ratio of Befesa (PK) is 19.15
What is the cash to sales ratio of Befesa (PK)?
The cash to sales ratio of Befesa (PK) is 0.91
What is the reporting currency for Befesa (PK)?
Befesa (PK) reports financial results in EUR
What is the latest annual turnover for Befesa (PK)?
The latest annual turnover of Befesa (PK) is EUR 1.22B
What is the latest annual profit for Befesa (PK)?
The latest annual profit of Befesa (PK) is EUR 57.97M
What is the registered address of Befesa (PK)?
The registered address for Befesa (PK) is 68-70 BOULEVARD DE LA PETRUSSE, LUXEMBOURG CITY, LUXEMBOURG, L-2320
What is the Befesa (PK) website address?
The website address for Befesa (PK) is www.befesa.com
Which industry sector does Befesa (PK) operate in?
Befesa (PK) operates in the SCRAP & WASTE MATERIALS-WHSL sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
DTEMFDitem Explorations (CE)
US$ 0.01
(999,900.00%)
1,000
RRMLFRoss River Minerals Inc (CE)
US$ 0.0089
(889,900.00%)
9.95k
SDCCQSmileDirectClub Inc (CE)
US$ 0.0003
(29,900.00%)
342.23k
COUVCorporate Universe Inc (CE)
US$ 0.0002
(19,900.00%)
73.97k
PRMDPrimeMD Inc (CE)
US$ 0.0002
(19,900.00%)
100
RAHGFRoan Holdings Group Company Ltd (CE)
US$ 0.000001
(-99.99%)
200
UBMRFUrbanimmersive Inc (CE)
US$ 0.000001
(-99.97%)
1.5k
UNDRUnderSea Recovery Corporation (CE)
US$ 0.000001
(-99.90%)
55k
ERHEERHC Energy Inc (CE)
US$ 0.000001
(-99.88%)
407
EICCFE Automotive Inc (CE)
US$ 0.0001
(-99.88%)
5.67k
PHILPHI Group Inc (PK)
US$ 0.0005
(0.00%)
463.99M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0002
(100.00%)
170.94M
HMBLHUMBL Inc (PK)
US$ 0.0009
(12.50%)
133.7M
RDARRaadr Inc (PK)
US$ 0.00155
(-8.82%)
119.97M
CGACCode Green Apparel Corp (PK)
US$ 0.0004
(-11.11%)
110.87M
marcis marcis 5 분 전
Your statement is 100% not true and misleading
The management put out a statement no R/S

Why late comers and flippers who sold think RDAR value is too much for cheapo traders
Posts 2021 style trading

Yeah we get it

NeXT impending doom a
RDAR
lovethatgreen lovethatgreen 5 분 전
Longtime no see
TORVF
waterchaser waterchaser 5 분 전
Ask Tony if he's dumping and get back to us.
USEI
janice shell janice shell 6 분 전
That makes sense.
Myth Myth 6 분 전
Storyville - Good Day For The Blues live

https://www.youtube.com/watch?v=Wu3vkHwxEaE
Trooperstocks Trooperstocks 6 분 전
$RELT - iQSTEL Announces Strategic Partnership with ONAR (Stock Symbol :RELT) to Elevate Market Position and Drive Investor Growth Through Rebranding https://finance.yahoo.com/news/iqst-iqstel-announces-strategic-partnership-110000628.html
RELT
tothe tothe 6 분 전
GDVM chart says we are in the right place. Close to crossing MA(50) since last September, MACD in reset, bear PSAR near possible flip to cover and Swing Traders may notice our exhaustion gap up.
~~ It is about time the TREND and MOMO indicators start backing up VOLUME MONEY that has been scr
GDVM
Trooperstocks Trooperstocks 6 분 전
$RELT - iQSTEL Announces Strategic Partnership with ONAR (Stock Symbol :RELT) to Elevate Market Position and Drive Investor Growth Through Rebranding https://finance.yahoo.com/news/iqst-iqstel-announces-strategic-partnership-110000628.html
RELT
attilathehunt attilathehunt 6 분 전
I agree!!


I am very positive on a positive outcome for L.

Being prepared for numerous outcomes is a shrewd decision.


Something to think about....

Here are some companies that might face increased competition if DCVax-L rec
NWBO
dexprs dexprs 7 분 전
A few more greens than reds now, but today still cannot be mistaken for a rally..
m$teamworkotc m$teamworkotc 7 분 전
like I said for years----the MMS indeed control stocks in these pink sewers....it will run when they are heavily LOADED
HMBL
dirkv dirkv 7 분 전
HIGH RISK!!!
Matinas BioPharma Holdings, Inc. (MTNB) : 0.51
I think a end value of 2.5 – 3 is possible If they find a buyer for MAT2203

Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sh
MTNB
rbb rbb 7 분 전
🤣 ...55/.56 break going to be big!
BURU
RMS555 RMS555 7 분 전
New Year will just bring more DILUTION according to your overview! Add more dilution next year on top of the 3.9 BILLION Shares diluted since September!

PSRU IS A SCAM , YOU KNOW THIS..... Xavier Mitchell, and YOU, are WANNABE's!!!!


.
PSRU
dirkv dirkv 7 분 전
HIGH RISK!!!
Matinas BioPharma Holdings, Inc. (MTNB) : 0.51
I think a end value of 2.5 – 3 is possible If they find a buyer for MAT2203

Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sh
MTNB
WinstonCup WinstonCup 7 분 전
Yes, we now know that MjLink buy in was just a scam that Ken ran.
WDLF
Trooperstocks Trooperstocks 7 분 전
$HNOI - "This teaming agreement solidifies a partnership that combines HNO's innovative hydrogen solutions with PHC's exceptional integration, distribution, and service expertise," said Don Owens, Chairman of HNO International. "Together, we are taking a significant step forward in advancing the hyd
HNOI
Trooperstocks Trooperstocks 7 분 전
$HNOI - "This teaming agreement solidifies a partnership that combines HNO's innovative hydrogen solutions with PHC's exceptional integration, distribution, and service expertise," said Don Owens, Chairman of HNO International. "Together, we are taking a significant step forward in advancing the hyd
HNOI
Trooperstocks Trooperstocks 7 분 전
$ACGX Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 https://finance.yahoo.com/news/alliance-creative-group-acgx-releases-133000169.html
ACGX
Trooperstocks Trooperstocks 8 분 전
$ACGX Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 https://finance.yahoo.com/news/alliance-creative-group-acgx-releases-133000169.html
ACGX
iclight iclight 8 분 전
The goalpost of buying/selling a stock is to make money unless you are an idiot.
NWBO
Fallingknife75 Fallingknife75 8 분 전
Reading is fun.

https://www.otcmarkets.com/stock/RDAR/news/Raadr-Inc-Announces-Agreement-with-Shareholders-for-the-Cancellation-of-17-Billion-Common-Shares-and-Affirms-No-Reverse-?id=456191

Knife
RDAR
biotechinvestor1 biotechinvestor1 8 분 전
Bristol-Myers: FDA approves nivolumab and hyaluronidase-nhy for subcutaneous injection
11:32 AM ET 12/27/2024 | Briefing.com
BMY
"On December 27, 2024, the Food and Drug Administration approved nivolumab and hyaluronidase-nhy (Opdivo Quantig, Bristol
Myers Squibb Company)
BMY
inventor1 inventor1 8 분 전
Please tell me you were looking in the mirror when you made that statement 💯🤣
HMBL

최근 히스토리

Delayed Upgrade Clock